These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 28211810)

  • 1. Therapeutics of Neurotransmitters in Alzheimer's Disease.
    Kandimalla R; Reddy PH
    J Alzheimers Dis; 2017; 57(4):1049-1069. PubMed ID: 28211810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitters in Prevention and Treatment of Alzheimer's Disease.
    Yang Z; Zou Y; Wang L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status and future directions of clinical trials in Alzheimer's disease.
    Plascencia-Villa G; Perry G
    Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease.
    Zhang F; Zhong RJ; Cheng C; Li S; Le WD
    Acta Pharmacol Sin; 2021 Sep; 42(9):1382-1389. PubMed ID: 33268824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
    Reddy PH
    J Alzheimers Dis; 2017; 57(4):969-974. PubMed ID: 28409748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
    Reddy AP; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective mitophagy in Alzheimer's disease.
    Pradeepkiran JA; Reddy PH
    Ageing Res Rev; 2020 Dec; 64():101191. PubMed ID: 33022416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug candidates in clinical trials for Alzheimer's disease.
    Hung SY; Fu WM
    J Biomed Sci; 2017 Jul; 24(1):47. PubMed ID: 28720101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.
    Kuruva CS; Reddy PH
    Drug Discov Today; 2017 Feb; 22(2):223-233. PubMed ID: 27794478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Alzheimers Dis; 2019; 72(s1):S145-S176. PubMed ID: 31594236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
    Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
    Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Natural Products and Alzheimer's Disease.
    Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
    Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
    Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
    Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease.
    Zhang M; Liu LY; Xu Y; Wang WZ; Qiu NZ; Zhang FF; Zhang F; Wang XD; Chen W; Xu XY; Gao YF; Chen MH; Li YQ; Zhang HT; Wang H
    Metab Brain Dis; 2023 Oct; 38(7):2465-2476. PubMed ID: 37256468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.